• Insilico Medicine Launches Phase III Trial for AI-Developed Drug

    Bio-IT World | Insilico Medicine is launching a phase III clinical program for rentosertib, its potentially first-in-class oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, age-related fibrotic lung disease with high unmet medical need. It is the next step in making AI-discovered drugs a reality for patients.

    Jul 8, 2026

  • Digital Brain Twin Tailor-Made for Autism Spectrum Disorder

    Bio-IT World | A new type of digital twin model of the brain, designed specifically for children with autism spectrum disorder, has been developed by researchers in Italy in hopes of enabling targeted treatment with transcranial magnetic stimulation at the exact location in the brain where neural circuits are misfiring. The computational feat raises the possibility of reversing the neurodevelopmental condition and exemplifies an “AI for good” application to help counterbalance fears about nefarious uses of artificial intelligence.

    Jul 7, 2026

  • Follow the Money: Inflammatory Bowel Disease Oral Drug, Breast, Colorectal Cancer ADCs, Other Next-Gen, Novel Treatments

    Bio-IT World | NewLimit plans to launch its first human clinical trial next year, testing a liver cell-reprogramming therapy; SonoThera advances its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic; Portal’s platform uses mechanoporation to deliver materials such as RNA, gene editors, probes, and antibodies; and more.

    Jul 1, 2026

  • Anthropic Launches Claude Science, Illumina's Spatial Insights Tool, Wellcome Sanger Institute, Google DeepMind AI Consortium

    Bio-IT World | Hartwig Medical Foundation and Ultima Genomics expand their strategic collaboration; Thermo Fisher launches its Invitrogen E-Gel Power Snap Lite Electrophoresis System; the Pistoia Alliance announces the next phase of its Identification of Medicinal Products Ontology; and more.

    Jun 30, 2026

  • The Spatial Biology Bottleneck: Why AI Models Fail on Complex Tissue & What Actually Fixes It

    Bio-IT World | The life sciences industry has spent years optimizing AI architectures for cell segmentation and generating benchmark comparisons that demonstrate impressive performance on clean, standardized tissues. Yet far less energy has gone into the one question that actually determines whether a model can handle unique morphology: does the training data reflect the structural complexity the model will encounter in the real world?

    Jun 26, 2026